Unlock AI-driven, actionable R&D insights for your next breakthrough.

Crosslinked Polyacrylic Acid: Comprehensive Analysis Of Synthesis, Properties, And Advanced Applications

MAR 23, 202662 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Crosslinked polyacrylic acid represents a critical class of synthetic polymers characterized by three-dimensional network structures formed through covalent bonding between polyacrylic acid chains and multifunctional crosslinking agents. This material exhibits exceptional water absorption capacity, mucoadhesive properties, and tunable rheological behavior, making it indispensable in pharmaceutical formulations, personal care products, battery electrode binders, and absorbent materials. The crosslinking density, monomer composition, and synthesis conditions critically determine the final performance characteristics, including swelling ratio, mechanical strength, and chemical stability.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Structure And Crosslinking Chemistry Of Crosslinked Polyacrylic Acid

Crosslinked polyacrylic acid is synthesized through free-radical polymerization of acrylic acid monomers in the presence of polyfunctional crosslinking agents, creating a three-dimensional macromolecular network. The polymer backbone consists of repeating units of –[CH₂–CH(COOH)]ₙ– with crosslinks established at intervals determined by the crosslinker concentration and reactivity 1. Common crosslinking agents include divinyl glycol 1, polyalkenyl polyethers (such as allyl sucrose) 3, and divinylbenzene (DVB) 15. The crosslinking reaction proceeds via radical addition to the vinyl groups of both the acrylic acid monomer and the crosslinker, forming covalent carbon-carbon bonds that interconnect polymer chains 48. The degree of crosslinking profoundly influences the polymer's physical and chemical properties. Low crosslink densities (0.3–1.0 mol% crosslinker relative to monomer) yield highly swellable hydrogels with water absorption capacities exceeding 100 g/g, suitable for superabsorbent applications 313. Moderate crosslinking (1.0–4.0 mol%) produces materials with balanced swelling and mechanical integrity, ideal for pharmaceutical excipients and thickening agents 25. High crosslink densities (4.0–20.0 mol%) generate rigid networks with reduced swelling but enhanced dimensional stability and ion-exchange capacity, applicable in potassium-binding therapies 1519. The molecular weight between crosslinks (Mc) inversely correlates with crosslink density and directly governs the elastic modulus and mesh size of the hydrogel network 14. Synthesis typically occurs in non-aqueous solvents such as acetone, ethyl acetate, or heptane to prevent premature hydration and facilitate controlled particle size distribution 12. Polymerization temperatures range from 35°C to reflux conditions (approximately 80–100°C at atmospheric pressure), with free-radical initiators like azobisisobutyronitrile (AIBN) or peroxides catalyzing the reaction 12. The resulting polymer is isolated by filtration, washed to remove residual monomers and solvents, and dried to yield a fine powder with average particle sizes below 10 microns without mechanical grinding 1. Advanced synthesis routes employ inverse emulsion polymerization using polysiloxane-polyalkylene-polyether copolymers as emulsifiers, enabling precise pH control and stable water-in-oil emulsions that invert to oil-in-water systems upon dilution 17.

Physicochemical Properties And Performance Metrics Of Crosslinked Polyacrylic Acid

The viscosity of crosslinked polyacrylic acid dispersions serves as a primary indicator of molecular weight and crosslink density. A 1% (w/v) aqueous dispersion of lightly crosslinked polymer exhibits viscosities exceeding 20,000 cPs at 25°C when measured with a Brookfield viscometer at 20 rpm 1. For pharmaceutical-grade polymers (e.g., Carbopol® series), viscosities at 10 g/L concentration and pH 7 typically range from 2,000 to 50,000 cPs, depending on the specific grade and crosslink architecture 3. Shear-thinning behavior is characteristic, with viscosity decreasing significantly at higher shear rates (e.g., 60 rpm vs. 0.6 rpm), which facilitates processing and application 5. Water absorption capacity, quantified as the swelling ratio or saline holding capacity, varies from 20 g/g to over 1,000 g/g depending on crosslink density and ionic strength of the medium 319. Superabsorbent polymers with crosslink densities below 0.5 mol% achieve swelling ratios exceeding 500 g/g in deionized water, but this decreases to 30–80 g/g in physiological saline (0.9% NaCl) due to ionic screening effects 1319. The equilibrium swelling ratio (Qeq) follows the Flory-Rehner equation, which accounts for polymer-solvent interaction parameters, crosslink density, and osmotic pressure contributions from ionized carboxyl groups 14. Mechanical properties include elastic modulus values ranging from 0.1 to 2.0 GPa for dried films, with the modulus increasing proportionally to crosslink density 3. Hydrated gels exhibit much lower moduli (1–100 kPa) due to plasticization by water molecules. Tensile strength and elongation at break are inversely related to swelling capacity; highly swollen gels are mechanically fragile, while densely crosslinked networks maintain structural integrity under stress 13. Dynamic mechanical analysis (DMA) reveals glass transition temperatures (Tg) between 80°C and 120°C for dry polymers, with Tg decreasing upon hydration 5. Chemical stability is excellent across a broad pH range (pH 3–10), with carboxyl groups remaining protonated below pH 4.5 (pKa ≈ 4.5 for acrylic acid) and fully ionized above pH 7 710. Thermal stability, assessed by thermogravimetric analysis (TGA), shows onset decomposition temperatures around 200–250°C, with major weight loss occurring between 300°C and 450°C due to decarboxylation and backbone degradation 11. Residual monomer content is a critical quality parameter; pharmaceutical-grade polymers must contain less than 500 ppm acrylic acid, achievable through post-polymerization washing and controlled storage conditions 12.

Synthesis Methodologies And Process Optimization For Crosslinked Polyacrylic Acid

Precipitation Polymerization In Non-Aqueous Media

Precipitation polymerization in non-aqueous solvents represents the most common industrial synthesis route for crosslinked polyacrylic acid 12. Acrylic acid monomer (typically 20–40 wt% relative to solvent) is dissolved in a solvent such as ethyl acetate, heptane, or a mixture of methylene chloride (60–75 vol%) and ethyl acetate (25–40 vol%) 2. A crosslinking agent (0.3–4.0 mol% relative to monomer) such as divinyl glycol or allyl sucrose is added, followed by a free-radical initiator (0.1–1.0 mol%) such as AIBN or benzoyl peroxide 13. The reaction mixture is heated to 35–80°C under inert atmosphere (nitrogen or argon) with continuous stirring at 200–500 rpm 2. Polymerization proceeds over 2–6 hours, during which the polymer precipitates as fine particles due to its insolubility in the organic medium 1. Post-polymerization processing involves filtration, washing with fresh solvent to remove unreacted monomer (reducing residual acrylic acid to <500 ppm), and drying at 60–80°C under vacuum to remove solvent (achieving residual solvent levels <5 ppm for methylene chloride) 2. The resulting powder exhibits particle sizes of 1–10 microns without grinding, high bulk density (0.4–0.6 g/cm³), and minimal electrostatic charge 3. Partial neutralization with potassium hydroxide or sodium hydroxide (10–30 mol% of carboxyl groups) can be performed in situ by adding an alcoholic solution of the base to the polymer dispersion before drying, enhancing flow properties and reducing hygroscopicity 110.

Inverse Emulsion Polymerization For Controlled pH Systems

Inverse emulsion polymerization enables synthesis of crosslinked polyacrylic acid with controlled pH without complete pre-neutralization of the monomer, addressing stability issues in conventional emulsion systems 17. An aqueous phase containing acrylic acid (30–50 wt%), crosslinker (0.5–2.0 mol%), and initiator (e.g., potassium persulfate, 0.1–0.5 mol%) is emulsified in a continuous oil phase (mineral oil or isoparaffin) using a polysiloxane-polyalkylene-polyether copolymer emulsifier (2–5 wt% relative to oil phase) 17. The emulsion is heated to 50–70°C with gentle agitation (100–200 rpm) for 1–3 hours, forming a stable water-in-oil emulsion with droplet sizes of 0.5–5 microns 17. The resulting inverse emulsion can be directly applied as a liquid thickener or inverted to an oil-in-water emulsion by dilution with water under high shear, yielding a stable dispersion of crosslinked polyacrylic acid microgels 17. This method avoids the need for drying and grinding, reduces dust formation, and enables precise control of polymer pH (pH 2.5–4.5 achievable without neutralization), which is critical for applications requiring acidic conditions such as denture adhesives and topical formulations 717.

Surface Crosslinking And Post-Polymerization Modification

Surface crosslinking involves treating pre-formed crosslinked polyacrylic acid particles with additional crosslinking agents to increase crosslink density selectively at the particle surface, creating a core-shell structure with a highly crosslinked shell and a lightly crosslinked core 518. Common surface crosslinkers include ethylene glycol diglycidyl ether, glycerol, and polyethylene glycol diacrylate, applied at 0.01–0.5 wt% relative to polymer 18. The polymer is mixed with an aqueous or alcoholic solution of the crosslinker and heated to 120–180°C for 10–60 minutes, during which the crosslinker diffuses into the particle surface and reacts with carboxyl groups via esterification or addition reactions 518. Surface-crosslinked polymers exhibit reduced swelling rates, enhanced gel strength, and improved resistance to mechanical shear, making them suitable for absorbent cores in diapers and feminine hygiene products 1118. The surface crosslinking process also reduces residual monomer content by promoting further polymerization of unreacted acrylic acid trapped within the particle matrix 12. Optimization of surface crosslinking conditions (temperature, time, crosslinker concentration) is critical to balance absorption capacity (which decreases with excessive surface crosslinking) and gel integrity (which improves with moderate surface crosslinking) 518.

Granulation And Flow Property Enhancement

Crosslinked polyacrylic acid powders often exhibit poor flow properties due to low bulk density (0.2–0.4 g/cm³), high electrostatic charge, and fine particle size (<10 microns), complicating handling and dosing in industrial applications 3. Granulation processes convert the fine powder into free-flowing granules with improved bulk density (0.5–0.8 g/cm³) and reduced dust generation 3. Wet granulation involves mixing the polymer powder with a binder solution (e.g., aqueous polyvinyl alcohol or hydroxypropyl cellulose at 1–5 wt%), followed by extrusion, spheronization, and drying at 60–80°C 3. Dry granulation employs roller compaction or slugging to form compacts, which are then milled and sieved to the desired granule size (100–500 microns) 3. Granulated crosslinked polyacrylic acid retains at least 70–90% of the thickening capacity of the original powder, with viscosities of 1,400–1,800 cPs at 10 g/L and pH 7 (compared to 2,000 cPs for the ungranulated powder) 3. The granules exhibit significantly improved flow rates (e.g., flow index >50 vs. <30 for powder), reduced fines content (<10% vs. >30% for powder), and minimal static adherence 3. These properties facilitate automated dispensing, blending with other excipients, and direct compression into tablets for pharmaceutical applications 3.

Applications Of Crosslinked Polyacrylic Acid In Pharmaceutical And Biomedical Fields

Mucoadhesive Drug Delivery Systems And Denture Adhesives

Crosslinked polyacrylic acid exhibits strong mucoadhesive properties due to hydrogen bonding and electrostatic interactions between carboxyl groups and mucin glycoproteins on mucosal surfaces 7. This property is exploited in buccal, nasal, and gastrointestinal drug delivery systems to prolong residence time and enhance bioavailability of therapeutic agents 7. Denture fixative compositions contain 10–40 wt% partially neutralized crosslinked polyacrylic acid (neutralization degree 20–50 mol%) combined with hydrophilic polymers such as sodium carboxymethylcellulose (10–30 wt%), hydroxypropyl guar (5–15 wt%), or sodium alginate (5–10 wt%) 7. The formulation is applied as a paste or powder to the denture surface, where it hydrates upon contact with saliva, forming a viscous adhesive layer that bonds the denture to the oral mucosa 7. Clinical studies demonstrate that denture adhesives containing crosslinked polyacrylic acid provide retention forces of 5–15 N (measured by tensile testing) for 6–12 hours, significantly outperforming formulations based solely on cellulose derivatives or gums 7. The adhesive strength depends on the degree of crosslinking (optimal at 0.5–1.5 mol% crosslinker), neutralization level (optimal at 30–40 mol%), and polymer molecular weight (optimal at 1–3 million Da) 7. Safety profiles are excellent, with no significant irritation or allergic reactions reported in long-term use studies 7.

Thickening Agents For Topical And Ophthalmic Formulations

Crosslinked polyacrylic acid serves as a high-efficiency thickening agent in topical gels, creams, and ophthalmic solutions, providing viscosities of 5,000–50,000 cPs at concentrations of 0.5–2.0 wt% 2. The polymer is dispersed in water or aqueous buffers and neutralized to pH 6.0–7.5 with triethanolamine, sodium hydroxide, or potassium hydroxide, inducing rapid swelling and viscosity development 210. The resulting gels exhibit pseudoplastic (shear-thinning) rheology, facilitating application and spreading while maintaining high viscosity at rest to prevent product separation 2. Pharmaceutical-grade crosslinked polyacrylic acids (e.g., Carbopol® 971P, 974P, 980) are synthesized in ethyl acetate and partially neutralized with potassium to minimize residual solvents (methylene chloride <5 ppm) and meet regulatory requirements for topical and ophthalmic use 2. These polymers are compatible with a wide range of active pharmaceutical ingredients, including antibiotics, corticosteroids, and nonsteroidal anti-inflammatory drugs, without affecting drug stability or release kinetics 2. Ophthalmic formulations benefit from the polymer's mucoadhesive properties, which prolong corneal contact time and enhance drug absorption, reducing dosing frequency from 4–6 times daily to 2–3 times daily 2.

Binders For Lithium-Ion Battery Electrodes

Crosslinked polyacrylic acid has emerged as a high-performance binder for lithium-ion battery electrodes, particularly for silicon-based anodes and high-nickel cathodes, due to its strong adhesion, electrochemical stability, and ability to accommodate volume changes during charge-discharge cycles 5. The binder is dispersed in water at 1–3 wt% concentration and mixed with active materials (e.g., graphite, silicon, LiNi₀.₈Co₀.₁Mn₀.₁O₂) and conductive additives (e.g., carbon black, carbon nanotubes) to form a slurry with viscosity of 2,000–8,000 cPs at 60 rpm 5. The slurry is coated onto copper or aluminum current collectors, dried at 80–120°C, and calendered to achieve electrode densities of 1.

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
THE B. F. GOODRICH COMPANYPharmaceutical mucoadhesive drug delivery systems, oral and gastrointestinal formulations requiring prolonged mucosal residence time.Carbopol PolycarbophilSynthesized in non-aqueous solvent with divinyl glycol crosslinker, producing particles <10 microns without grinding, viscosity >20,000 cPs at 1% concentration, strong mucoadhesive properties.
3V INC.Topical gels, creams, and ophthalmic solutions as thickening agents in pharmaceutical and cosmetic formulations.Pharmaceutical-grade Crosslinked Polyacrylic AcidPolymerized in methylene chloride-ethyl acetate mixture with residual methylene chloride <5 ppm, suitable for topical and ophthalmic applications, meets regulatory requirements for pharmaceutical use.
NOVEON IP HOLDINGS CORP.Pharmaceutical tablet formulations, controlled-release systems requiring improved handling and automated dispensing in manufacturing processes.Carbopol Granulated PolymersGranulated form with improved flow properties (flow index >50), bulk density 0.5-0.8 g/cm³, retains 70-90% thickening capacity (1400-1800 cPs at 10 g/L, pH 7), reduced dust and static adherence.
TOAGOSEI CO. LTD.Lithium-ion battery electrode binders for electric vehicles and energy storage systems requiring high adhesion and electrochemical stability.Battery Electrode BinderOptimized viscosity balance for uniform mixing with active materials, enhanced binding properties and dispersion stability, suitable for silicon-based anodes and high-nickel cathodes.
BLOCK DRUG CO. INC.Denture adhesive products for oral care applications requiring long-lasting fixation and biocompatibility.Denture Fixative FormulationPartially neutralized crosslinked polyacrylic acid (20-50 mol% neutralization) provides retention forces of 5-15 N for 6-12 hours, superior mucoadhesion with no irritation.
Reference
  • Crosslinked polyacrylic acid
    PatentInactiveUS5221722A
    View detail
  • Crosslinked polyacrylic acids having low solvent residue, a process for the preparation thereof and the use thereof as thickening agents
    PatentInactiveUS5342911A
    View detail
  • Controlled release polyacrylic acid granules and a process for preparing the same
    PatentInactiveUS6762267B2
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png